Neoplasma. 2017;64(6):962-970. doi: 10.4149/neo_2017_620.
Thymidylate synthetase (TS) plays a critical role in the de novo synthesis of dTMP inside the cell. Therefore, TS is a suitable target for cytotoxic drugs such as fluoropyrimidines. Drug efficacy and toxicity depend on the intracellular level of TS, which is significantly influenced by the polymorphisms in the 5'UTR (TSER - rs45445694, TSER3G>C - rs2853542) and 3'UTR (1494del TTAAAG - rs151264360) of TYMS gene. Polymorphic variants of TYMS gene affect TS activity via gene expression and transcript stability. Patients who undergo fluoropyrimidine therapy may benefit from genetic testing prior to the administration of chemotherapy. At the 5' terminus of TYMS, there is a polymorphic region represented by a variable number of 28bp long tandem repeats (2-9 tandems) with the G or C nucleotide variant (SNP G>C). The 3'end of TYMS gene may decrease the stability of mRNA in the case of 6 base deletion (1494del6, D). In our study, we have focused on testing of TYMS gene polymorphisms, determination of TYMS variant frequencies in Western Slavic population and comparison of Slovak population with other populations.We performed identification of 5'UTR (rs45445694 - TSER2 or TSER3; rs2853542 - TSER3G>C; TSER3+ins6) and 3'UTR (rs151264360/1494del6/D) polymorphic regions of TYMS gene among 96 volunteers by PCR-RFLP and fragment analysis. Slovak frequencies of selected polymorphisms were established as follows: the frequency of TSER2, TSER3, TSER3G>C, 1494del6/D and I to be 41%, 59%, 34%, 37.5% and 62.5% respectively. The high resolution of the capillary electrophoresis technique allowed among TSER3 group identification of a subgroup of four individuals with rare 6bp insertion in 3R allele, id est 2.1% TSER3+ins6 allele frequency. In our study, we have revealed individuals with rare G>C substitution in the first 28bp tandem repeat of TSER*2 promoter enhancer region (rs183205964) as well, the overall frequency of this polymorphic allele in Slovak population was 2.1%. Our results proved that Slovak population is in Hardy-Weinberg equilibrium and proportion of TYMS polymorphisms is in accordance with other published data.
胸苷酸合成酶 (TS) 在细胞内从头合成 dTMP 中起着关键作用。因此,TS 是氟嘧啶类细胞毒性药物的合适靶点。药物疗效和毒性取决于细胞内 TS 水平,而 TS 水平受 TYMS 基因 5'UTR(TSER-rs45445694、TSER3G>C-rs2853542)和 3'UTR(1494delTTAAAG-rs151264360)多态性的显著影响。TYMS 基因的多态性变体通过基因表达和转录稳定性影响 TS 活性。接受氟嘧啶治疗的患者在接受化疗前可能受益于基因检测。在 TYMS 基因的 5'末端,存在一个由 28bp 长串联重复(2-9 个串联)组成的多态性区域,其 G 或 C 核苷酸变体(SNP G>C)。TYMS 基因 3'端的 6 个碱基缺失(1494del6,D)可能会降低 mRNA 的稳定性。在我们的研究中,我们专注于测试 TYMS 基因多态性,确定西方斯拉夫人种中的 TYMS 变体频率,并将斯洛伐克人群与其他人群进行比较。我们通过 PCR-RFLP 和片段分析在 96 名志愿者中鉴定了 TYMS 基因的 5'UTR(rs45445694-TSER2 或 TSER3;rs2853542-TSER3G>C;TSER3+ins6)和 3'UTR(rs151264360/1494del6/D)多态性区域。选定多态性的斯洛伐克频率如下:TSER2、TSER3、TSER3G>C、1494del6/D 和 I 的频率分别为 41%、59%、34%、37.5%和 62.5%。毛细管电泳技术的高分辨率允许在 TSER3 组中鉴定出一个罕见的 3R 等位基因中 6bp 插入的四个人的亚组,即 2.1% TSER3+ins6 等位基因频率。在我们的研究中,我们还发现了 TSER*2 启动子增强子区域前 28bp 串联重复中罕见的 G>C 取代个体(rs183205964),斯洛伐克人群中这种多态性等位基因的总体频率为 2.1%。我们的结果证明,斯洛伐克人群处于哈迪-温伯格平衡状态,TYMS 多态性的比例与其他已发表的数据一致。